HOME JOURNALS CONTACT

Journal of Medical Sciences

Year: 2008 | Volume: 8 | Issue: 8 | Page No.: 691-698
DOI: 10.3923/jms.2008.691.698
Lipid Profile and Lipid Peroxidation among Ghanaian Pregnancy-Induced Hypertensives
L. Ahenkorah, W.K. B.A. Owiredu, E. F. Laing, N. Amidu and C. A. Turpin

Abstract: This study was aimed at investigating oxidative stress among Ghanaian women with Pregnancy-Induced Hypertension (PIH). One hundred Pregnancy-Induced Hypertension women: Thirty with preeclampsia, seventy with gestational hypertension and fifty normotensive pregnant women (controls) in the second half of pregnancy were recruited for this study. There was a significant increase in triglycerides and LDL-cholesterol in the subject groups compared to the control. Malondialdehyde (MDA), the lipid peroxidation marker among the PIH subjects was significantly increased as compared to the normotensive pregnant women (controls). A significant positive correlation between MDA and blood pressure (Systolic and Diastolic blood pressure) was also observed. This study clearly indicates that Ghanaian women presenting with PIH are very prone to dyslipidemia as well as lipid peroxidation, this might in part explain the oxidative stress and endothelial vascular dysfunction observed in these group of women.

Fulltext PDF Fulltext HTML

How to cite this article
L. Ahenkorah, W.K. B.A. Owiredu, E. F. Laing, N. Amidu and C. A. Turpin, 2008. Lipid Profile and Lipid Peroxidation among Ghanaian Pregnancy-Induced Hypertensives. Journal of Medical Sciences, 8: 691-698.

Keywords: Pregnancy, induced hypertension, malondialdehyde, normotensive pregnant women, oxidative stress and anthropometric data

INTRODUCTION

Pregnancy-Induced Hypertension (PIH) continues to be a major obstetric problem in present-day healthcare practice. It presents a great medical dilemma because it affects not only maternal health but also puts foetal development at risk. Worldwide, the hypertensive disorders of pregnancy are very common and are responsible for 12% of maternal mortality during pregnancy and the puerperium (Bellany et al., 2007). Preeclampsia is the leading cause of maternal mortality in developed countries and is associated with a five-fold increase in perinatal mortality; the major cause of foetal compromise is reduced uteroplacental perfusion (Hubel, 1999). In Ghana, an alarming 40% of maternal deaths are as a result of hypertensive pregnancy, antepartum haemorrhage and post partum haemorrhage (Osei-Nketiah, 2001).

Gestational Hypertension (GH) and preeclampsia (PE) (together referred to as PIH) are conditions of pregnancy characterized by increased blood pressure. Preeclampsia, according to the National High Blood Pressure Education Program of the USA (1990) is defined as hypertension developing after 20 weeks’ gestation with proteinuria and/or oedema. Gestational hypertension on the other hand, is hypertension developing after 20 weeks’ gestation without other signs of preeclampsia. Preeclampsia is a systemic disease characterized not only by hypertension but also by increased peripheral vascular resistance, diffuse endothelial dysfunction, proteinuria and coagulopathy (Solomon and Seely, 2001). In the absence of severe disease manifestations, discrimination between preeclampsia and gestational hypertension may be difficult but usually the distinction is often made solely on the basis of urine protein determination, frequently by dipstick protein measurement (Meyer et al., 1994).

In spite of varying attempts to comprehend the primary pathophysiology of PIH, no particular theory regarding its origin has been established yet and this limits the ability to prevent and treat this medical condition. Varying hypothesis have been put forward for this obstetric disorder, including immune, genetic, placental abnormalities (Seely and Solomon, 2003) and endothelial dysfunction (Roberts, 1998). Some pregnant women with PIH may also present with dyslipidemia (Belo et al., 2002; Sattar et al., 1997a). There is increasing evidence that endothelial cell dysfunction is the primary pathophysiological mechanism which causes preeclampsia (Friedman et al., 1991; Roberts et al., 1989). However, the pathway mediating endothelial cell layer dysfunction still remains unclear. One hypothesis receiving amplified attention is that the endothelial dysfunction may be the result of increased oxidative stress, which is characterized by disequilibrium between oxidant and antioxidant forces in favour of oxidation. The lipid peroxidation process, initiated by the reaction of free radicals with polyunsaturated fatty acids (Hubel et al., 1989) is used as a marker of oxidant force.

Lipid peroxidation is a reaction whereby molecular oxygen is incorporated into poly-unsaturated fatty acids (PUFA) to yield lipid peroxides. Lipid peroxidation mediated by free radicals is considered to be the major mechanism of cell membrane destruction and cell damage (endothelial damage) and is a key contributing factor to the pathophysiologic condition of preeclampsia (Ozan et al., 2002). Diverse studies world wide have reported elevated lipid levels in PIH patients (GH and PE) (Kaaja et al., 1995; Sattar et al., 1997a; Seely and Solomon, 2003; Forest et al., 2005; Turpin et al., 2008). Cell membranes are generally made up of lipid bilayers and thiol containing proteins. The unsaturated lipid component and thiol containing proteins of the cell membranes are susceptible to free radical attack. Antioxidants are compounds that dispose, scavenge and suppress the formation of free radicals, or oppose their actions (Sies, 1991). Free radicals are formed in both physiological and pathological conditions in mammalian tissues (Krishna Mohan and Venkataramana, 2007; Plaa and Witschi, 1976). But normally, defense mechanisms of the body play an important role in the form of antioxidants, making every effort to minimize the damage, as an adaptation to stressful situations. An increased disequilibrium between oxidants (free radicals) and antioxidants results in oxidative stress when the imbalance favours oxidation. The unrestrained production of free radicals is considered as an important factor in the tissue damage induced by several conditions (Sato et al., 1996) as reportedly observed in PIH patients (Mutlu-Turkoglu et al., 1998). There is considerable epidemiological, laboratory and clinical evidence to suggest a significant role for free radical activation and deficient or over utilized antioxidant defenses in the pathogenesis of PIH (Gulmezoglu et al., 1997). This current study, therefore, was aimed at investigating the possible link between the lipidaemic status, lipid peroxidation and oxidative stress in PIH women as compared to normotensive pregnant women.

MATERIALS AND METHODS

Subjects: This study was conducted at the Komfo Anokye Teaching Hospital in Kumasi, Ashanti Region of Ghana between November, 2006 and December, 2007 and was approved by the SMS/KATH Committee on Human Research Publications and Ethics (CHRPE/KNUST/KATH/15_03_08). Two groups of women within the age group 17-45 years, comprising of one hundred pregnant women with Pregnancy-Induced Hypertension (seventy with gestational hypertension and thirty with preeclampsia) and fifty normotensive pregnant women with uncomplicated pregnancy visiting the Obstetrics and Gynaecology Department of the Hospital were recruited for the study. Most importantly, women with known renal disease, diabetes and hypertension prior to pregnancy or cardiovascular diseases were excluded from this study in both test and control. Smokers were also excluded from the study, since the constituents present in cigarette are potential sources of oxidative degradation of membrane lipids.

Pregnant women with normal blood pressure and without proteinuria were included in the control group. Eligible cases were pregnant women within the age range 17-45 years and who met the criteria of the National High Blood Pressure Education Program Working Group for PIH assessed by a single qualified Obstetrician/Gynaecologist. Briefly, the presence of high blood pressure on two occasions six hours apart was considered gestational hypertension while pregnant women who had proteinuria level of 2+ positive result on a dipstick, were considered as presenting with preeclampsia (Forest et al., 2005). All the subjects were Ghanaians and their participation was voluntary and informed consent was obtained from each of them.

Sample collection and preparation
Biochemical analysis: Fasting venous blood samples were drawn from the respondents between 7 am and 11 am. About 5 mL was drawn and dispensed into vacutainer® plain tubes which were then taken to the laboratory within an hour for centrifugation; the serum obtained was used for the biochemical assay. Biochemical assays on the serum were performed with the ATAC® 8000 Random Access Chemistry System (Elan Diagnostics, Smithfield, RI, USA). Parameters that were determined include: Total Cholesterol (TC), Triglycerides (TG), High density lipoprotein cholesterol (HDL-C), Low density lipoprotein cholesterol (LDL-C), Very low density lipoprotein cholesterol (VLDL-C). Serum LDL cholesterol (LDL-C) was calculated using the Frederickson-Friedewald’s formula according to which LDL-C = TC - (HDL-C + VLDL-C). VLDL-C was calculated as 1/5 of triglycerides. Atherogenic index (AI) = [(total cholesterol-HDL cholesterol)/HDL cholesterol] (Schonfeld, 1979). The methods adopted by the automated instrument for the determination of the above parameters are according to the reagent manufacturer’s instruction- JASTM diagnostics, Inc. (JASTM Diagnostics, Inc. Miami Florida, USA). Total Cholesterol Determination was determined according to the method described by Trinder (1969), Triglycerides determination employs a modified Trinder method (Trinder, 1969; Bartham and Trinder, 1972).

Low Density Lipoprotein cholesterol (LDL) determination: LDL was calculated according to Friedewald formula in accordance to the manufacturer’s instructions.

LDL = TC - (HDL-C + VLDL)

Malondialdehyde (MDA) determination: MDA levels were determined by the MDA-Thiobarbituric acid (TBA) test which is the colorimetric reaction of MDA and TBA in acid solution. TBA reacted with MDA, a secondary product from lipid peroxidation, which generated an adduct of red colour, which was detected spectrophotometrically. This method is a fast, sensitive and low-cost method that can be used to indicate the extent of lipid peroxidation in a variety of systems (Shlafer and Shepard, 1984). The protocol used in this study is the (Kamal et al., 1989) modification of the (Shlafer and Shepard, 1984) protocol which is as follows:

About 0.5 mL of serum was treated with 2.5 mL of 20% trichloroacetic acid (TCA) and then 1 mL of 0.67% TBA. The mixture was incubated at 100°C for 30 min. After cooling, the sample was extracted with 4 mL n-butanol and centrifuged at 3000 rpm for 10 min. The absorbance of the supernatant was measured at 535 nm and the results were expressed as μmol L-1, using the extinction coefficient of 1.56x105 L mmol-1 cm.

Urinalysis: Early morning urine was collected in plastic containers from the respondents and urine protein was analyzed using the dip-stick qualitative method (CYBOWTM DFI Co Ltd., Gimhae-City, Republic of Korea).

Anthropometric variables
Measurements: Anthropometric measurements included height, measured without shoes and weight to nearest 0.1 kg in light clothing. Subjects were weighed on a bathroom scale (Zhongshan Camry Electronic Co. Ltd., Guangdong, China) and their height measured with a wall-mounted ruler. BMI was calculated by dividing weight (kg) by height squared (m2).

Blood pressure: Blood pressure was taken by qualified obstetric nurses using a mercury sphygmomanometer and stethoscope. Measurements were taken from the left upper arm after subjects had been sitting for >5 min in accordance with the recommendation of the American Heart Association (Kirkendall et al., 1967). Triplicate measurements were taken with a 5 min rest interval between measurements and the mean value was recorded.

Statistical analysis: Values for the continuous variables are expressed as their Mean±SEM. Comparisons of the women with PIH (Gestational Hypertension and Preeclampsia separately and combined) against the control group were performed using unpaired students t-tests, a level of p<0.05 was considered as statistically significant. Comparison of clinical variables and blood lipid profiles between hypertensive and control groups was by Pearson Correlation Coefficient. Correlation was significant at the 0.05, 0.01 and 0.001 levels (2-tailed). GraphPad Prism version 5.00 for windows was used for statistical analysis (GraphPad software, San Diego California USA, http://www.graphpad.com).

RESULTS

Clinical data were collected from the PIH, PE, GH and control (CG) groups to characterize the study groups (Table 1). All the studied groups had similar mean age and mean pregnancy period. Indices of obesity (weight and BMI) were significantly increased in the entire studied group as compared to the control group. Mean SBP and DBP were significantly increased in PIH, PE and GH as was expected from the inclusion criteria. Proteinuria was also significantly increased when PIH and PE were compared to the control group.

From the lipid profile, plasma triglyceride and LDL-C levels were significantly higher in the various subject groups than in the controls, whereas the plasma HDL-C concentrations were much lower in these groups than in the control group, though it did not attain significant level. Total cholesterol, atherogenic index and VLDL concentrations were also not statistically different (Table 2). We have also calculated the ratios between different lipid fractions like LDL-C : HDL-C; TC : HDL-C; TG : HDL-C and HDL-C : VLDL-C. In the present study there was a significant rise in TG : HDL-C in the studied group as compared to control group.

The significant increase in the level of MDA in the various subject groups as compared to the control group was most pronounced when PE was compared to the control group (Fig. 1).

Fig. 1: Malondialdehdye levels in the various subject groups as compared to the control group. For Pregnancy-Induced Hypertension (PIH), n = 100, Preeclampsia (PE), n = 30, Gestational Hypertension (GH), n = 70, Control Group (CG), n = 50

Table 1:

Clinical characteristics of PIH and normotensive pregnant women

Values are given as Means±SEM. Proteinuria values represent range. 0, 0.1, 0.3, 1 and 5 g L-1 corresponds to negative, trace, +, ++ and +++ in dipstick testing, respectively. ***p<0.0001, **p<0.001, *p<0.05 compared with normal pregnancy (Unpaired Student’s t-test). For Pregnancy-Induced Hypertension (PIH), n = 100, Preeclampsia (PE), n =30, Gestational Hypertension (GH), n = 70, Control Group (CG), n = 50


Table 2: Blood lipids in normotensive pregnancy and PIH
Atherogenic index = [(total cholesterol-HDL cholesterol)/HDL cholesterol]. For Pregnancy-Induced Hypertension (PIH), n = 100, Preeclampsia (PE), n = 30, Gestational Hypertension (GH), n = 70, Control Group (CG), n = 50

Table 3: Pearson correlation co-efficient between clinical variables and lipid profile for PIH (Lower left-hand side) and CG (Upper right-hand side)
*Correlation is significant at the 0.05 level (2-tailed), **Correlation is significant at the 0.01 level (2-tailed), ***Correlation is significant at the 0.001 level (2-tailed). SBP: Systolic blood pressure, DBP: Diastolic Blood Pressure, BMI: Body Mass Index, TC: Total serum cholesterol, GA: Gestation age, WT: Weight, HDL: High Density Lipoprotein, LDL: Low Density Lipoprotein, VLDL: Very Low Density Lipoprotein, AI: Atherogenic Index, MDA: Malondialdehyde

Table 4:

Pearson correlation coefficients between clinical variables and lipid profile for PE (Lower left-hand side) and GH (Upper right-hand side)

*Correlation is significant at the 0.05 level (2-tailed), **Correlation is significant at the 0.01 level (2-tailed), ***Correlation is significant at the 0.001 level (2-tailed). SBP: Systolic Blood Pressure, DBP: Diastolic Blood Pressure, BMI: Body Mass Index, TC: Total serum cholesterol, GA: Gestation age, WT: Weight, HDL: High Density Lipoprotein, LDL: Low Density Lipoprotein, VLDL: Very Low Density Lipoprotein, AI: Atherogenic Index, MDA: Malondialdehyde

Generally, there is no significant correlation between the clinical variables and lipid profile in relation to MDA within the control group. However, there is a significant positive correlation between blood pressure (SBP and DBP) and MDA among the PIH group (Table 3). Apart from VLDL and AI which gave significant positive correlation with MDA among both PE and GH, age, TC and TG also correlate positively with MDA among PE subjects. SBP and GA are additional factors that correlate significantly with MDA among the GH group (Table 4).

Apart from HDL which gave a negative but significant correlation with AI within the control group, TC, LDL and TG correlate positively with AI. With the exception of LDL which indicates a negative but significant correlation, TC, HDL and TG indicated significant positive correlation with AI among the PIH subjects (Table 3). Similar to PIH, subjects within the PE subgroup gave significant negative correlation between LDL and DBP in relation to AI and a significant positive correlation with age, HDL, TG and VLDL. Also, in both the control group (CG) and GH group, AI showed significant positive correlation with TG, LDL and VLDL and negative significant correlation with HDL (Table 4).

LDL gave a significant negative correlation with HDL among all the studied groups except for PE where the negative correlation did not reach a significant level (Table 3, 4). Among the PIH group, TC showed a significant positive correlation with HDL, TG and LDL (Table 3); where as among the PE group, there was a positive correlation between TC and HDL, TG, LDL as well as VLDL (Table 4).

DISCUSSION

The literature suggests that PIH (PE and GH) is a widespread inflammatory state where a number of plasma factors that regulate endothelial functions are altered (Gratacos, 2000; Williams and de Swiet, 1997). An endothelial hyperstimulation is initially provoked, eventually leading to severe endothelial dysfunction and resulting in distributed microangiopathic disease with vasospasm and hypercoagulation (Cekmen et al., 2003; Gratacos, 2000).

Increased BMI examined in the present study could partly explain the significant increase in TG and LDL because increase in weight and BMI is associated with increase in body fat percentage levels. It is known that PIH (PE and GH) is associated with hypertriglyceridemia (Williams and de Swiet, 1997). This study also confirmed the increases in the level of triglyceride among these groups as compared to the control. The principal modulator of this hypertriglyceridemia is oestrogen as pregnancy is associated with hyperoestrogenaemia. Oestrogen induces hepatic biosynthesis of endogenous triglycerides, by increasing the hepatic VLDL-TG synthesis and secretion and plasma TG concentration (Glueck et al., 1975). This process may be modulated by hyperinsulinism found in pregnancy (Adegoke et al., 2003). The above mentioned interactions along with increased endothelial triglyceride accumulation may result in endothelial cell dysfunction during gestation (Mikhail et al., 1995). Increased TG, found in pregnancy induced hypertension, is likely to be deposited in predisposed vessels, such as the uterine spiral arteries and contributes to the endothelial dysfunction, both directly and indirectly through generation of small, dense LDL (Sattar et al., 1997a). Moreover, this hypertriglyceridemia may be associated with hypercoagulability (Kokia et al., 1990).

Additionally, in this study, significantly high levels of LDL-C concentration were found in Ghanaian women presenting with PIH, PE and GH. However, total cholesterol and AI levels in these groups did not reach significant levels. These results are consistent with the findings reported in studies of other populations (Cekmen et al., 2003). A significant fall in LDL-C concentration in the control group as observed in this present study may be attributed to hyperoestrogenaemia, while LDL-C levels increased significantly in the PIH subjects (Hubel et al., 1998; Sattar et al., 1997b). Moreover, other studies have also demonstrated that there is a predominance of the atherogenic small low-density lipoproteins (LDL) and that vascular cell adhesion molecules are increased in association with hyperlipidemia in PIH (PE and PE) (Hubel et al., 1998; Sattar et al., 1997a). Though the relevance of the lipid profile ratios (LDL-C/HDL-C; TC/HDL-C; TG/HDL-C and HDL-C/VLDL-C) in pregnancy and PIH is yet to be established, the significance of altered TG/HDL-C ratios cannot be overlooked as it may indicate additional risks in PIH.

The endothelial dysfunction in PIH could originate from oxidative stress as well as dyslipidaemia. Free radicals can be generated by many different enzymatic processes. They are extremely reactive and interact with polyunsaturated fatty acids to produce lipid peroxides with a much longer half-life (Gratacos, 2000; Madazli et al., 1999; Williams and de Swiet, 1997).

The increase in MDA levels found in this study is in agreement with the results of other studies (Jain and Wise, 1995; Madazli et al., 1999) which support the notion that lipid peroxidation is an important factor in the pathogenesis of PIH (PE and GH). Furthermore, serum MDA levels were highest in the PE group than PIH and GH (Fig. 1). These results suggest that the extent of lipid peroxidation probably correlates with the severity of the disorder. The increase in MDA is strongly related to lipid peroxidation caused by oxidative stress and is expected to affect various tissues and organ systems, including vascular endothelium. When oxidative stress reaches a certain level, cellular damage occurs, including structural damage in cellular membranes, in mitochondrial and nuclear DNAs and impairment of enzymatic functions at multiple levels. Oxidative stress can have an effect mainly on endothelial vessels and on many tissues and organs both locally and systematically (Cekmen et al., 2003). During these processes, other molecules involved in vasodilatation such as nitric oxide are inhibited by high lipid peroxide concentration (Gratacos, 2000; Williams and de Swiet, 1997). Presumably, all these circumstances may play roles in the ethiopathogenesis of hypertension in PIH.

There have been studies which suggested that endothelial changes in PIH pathophysiology might be related to either an increase or a decrease in the synthesis of nitric oxide (NO). The NO and MDA levels may possibly be related to the pathogenesis of PIH (PE and GH) because, dysfunction of endothelial cells can contribute to inappropriate vasoconstriction and platelet aggregation which are early signs of atherosclerosis, hypertension and coronary vasospasm (Vane and Botting, 1992) Evidence indicates that NO can have either a pro-oxidant or an anti-oxidant effect on lipid peroxidation, depending on a variety of contingent factors (Paternoster et al., 1999). At relatively high concentrations, NO can attenuate membrane dysfunction and tissue injury, while acting as a reactive oxygen metabolite (D’Ischia et al., 2000).

On the other hand, when generated at lower concentrations in the presence of oxygen, superoxide and other reactive oxygen species, NO can be converted into a range of potent oxidants (such as nitrogen dioxide and peroxynitrite) which might amplify and exacerbate the harmful effects of lipid peroxidation (O’Donnell et al., 1997). The reduced release of vasodilating agents such as nitric oxide (NO) may lead to hypertension (Erel et al., 1999). NO is a potent vasodilatator and is thought to have a major effect on gestational vasodilatation (Ludwig et al., 1997; Narin et al., 2000). Altered production of NO by the vascular endothelium may influence the pathogenesis of pre-eclampsia (Ludwig et al., 1997; Narin et al., 2000). This could probably explain the significant positive correlation between blood pressure and MDA among the PIH group.

CONCLUSION

In conclusion, the findings of this current study suggest that an abnormal lipid metabolism and particularly high triglycerides, LDL-C and lipid peroxides may contribute to the promotion of oxidative stress and vascular dysfunction seen in PIH and preeclampsia. It is, therefore, imperative that, blood lipid concentrations and lipid peroxides be evaluated in pregnant women during antenatal care since it could be helpful in the early detection and prevention of obstetric complications such as PIH.

REFERENCES

  • Adegoke, O.A., E.E. Iyare and S.O. Gbenebitse, 2003. Fasting plasma glucose and cholesterol levels in pregnant Nigerian women. Nig. Postgraduate Med. J., 10: 32-36.
    PubMed    Direct Link    


  • Bellamy, L., J.P. Casas, A.D. Hingorani and D.J. Williams, 2007. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: Systematic review and Meta-analysis. Br. Med. J., 335: 974-974.
    PubMed    


  • Belo, L., M. Caslake, D. Gaffney, A. Santos-Silva, L. Pereira-Leite, A. Quintanilha and I. Rebelo, 2002. Changes in LDL size and HDL concentration in normal and preeclamptic pregnancies. Atherosclerosis, 162: 425-432.
    PubMed    Direct Link    


  • Cekmen, M.B., A.B. Erbagci, A. Balat, C. Duman, H. Maral, K. Ergen, M. Ozden, O. Balat and S. Kuskay, 2003. Plasma lipid and lipoprotein concentrations in pregnancy induced hypertension. Clin. Biochem., 36: 575-578.
    Direct Link    


  • D'Ischia, M., A. Palumbo and F. Buzzo, 2000. Interactions of nitric oxide with lipid peroxidation products under aerobic conditions: Inhibitory effects on the formation of malondialdehyde and related thiobarbituric acid-reactive substances. Nitric Oxide, 4: 4-14.
    CrossRef    Direct Link    


  • Erel, C.T., L.M. Senturk, E. Oral, H. Mutlu, U. Colgar, H. Seyisoglu and E. Ertungealp, 1999. Results of the ACTH stimulation test in hirsute women. J. Reprod. Med., 44: 247-252.
    Direct Link    


  • Forest, J.C., J. Girouard, J. Masse, J.M. Moutquin, A. Kharfi, R.B. Ness, J.M. Roberts and Y. Giguere, 2005. Early occurrence of metabolic syndrome after hypertension in pregnancy. Obstet Gynecol., 105: 1373-1380.
    CrossRef    PubMed    Direct Link    


  • Friedman, S.A., R.N. Taylor and J.M. Roberts, 1991. Pathophysiology of preeclampsia. Clin. Perinatol., 18: 661-682.
    Direct Link    


  • Glueck, C.J., R.W. Fallat and D. Scheel, 1975. Effects of estrogenic compounds on triglyceride kinetics. Metabolism, 24: 537-545.
    CrossRef    Direct Link    


  • Gratacos, E., 2000. Lipid-mediated endothelial dysfunction: A common factor to preeclampsia and chronic vascular disease. Eur. J. Obstet. Gynecol. Reprod. Biol., 92: 63-66.
    Direct Link    


  • Gulmezoglu, A.M., G.J. Hofmeyr and M.M. Oosthuisen, 1997. Antioxidants in the treatment of severe pre-eclampsia: An explanatory randomised controlled trial. Br. J. Obstet. Gynaecol., 104: 689-696.
    Direct Link    


  • Hubel, C.A., 1999. Oxidative stress in the pathogenesis of preeclampsia. Proc. Soc. Exp. Biol. Med., 222: 222-235.
    Direct Link    


  • Hubel, C.A., F. Lyall, L. Weissfeld, R.E. Gandley and J.M. Roberts, 1998. Small low-density lipoproteins and vascular cell adhesion molecule-1 are increased in association with hyperlipidemia in preeclampsia. Metabolism, 47: 1281-1288.
    CrossRef    PubMed    


  • Hubel, C.A., J.M. Roberts, R.N. Taylor, T.J. Musci, G.M. Rogers and M.K. McLaughlin, 1989. Lipid peroxidation in pregnancy: New perspectives on preeclampsia. Am. J. Obstet. Gynecol., 161: 1025-1034.
    Direct Link    


  • Jain, S.K. and R. Wise, 1995. Relationship between elevated lipid peroxides, vitamin E deficiency and hypertension in preeclampsia. Mol. Cell. Biochem., 151: 33-38.
    CrossRef    Direct Link    


  • Kaaja, R., M.J. Tikkanen, L. Viinikka and O. Ylikorkala, 1995. Serum lipoproteins, insulin and urinary prostanoid metabolites in normal and hypertensive pregnant women. Obstet. Gynecol., 85: 353-356.
    CrossRef    PubMed    Direct Link    


  • Kamal, A.A., A. Gomaa, M. El-Khafif and A.S. Hammad, 1989. Plasma lipid peroxides among workers exposed to silica or asbestos dusts. Environ. Res., 49: 173-180.
    PubMed    


  • Kirkendall, W.M., A.C. Burton, F.H. Epstein and E.D. Freis, 1967. Recommendations for human blood pressure determination by sphygmomanometers. Circulation, 36: 980-988.
    CrossRef    PubMed    Direct Link    


  • Kokia, E., G. Barkai, B. Reichman, P. Segal, B. Goldman and S. Mashiach, 1990. Maternal serum lipid profile in pregnancies complicated by hypertensive disorders. J. Perinat. Med., 18: 473-478.
    Direct Link    


  • Krishna Mohan, S. and G. Venkataramana, 2007. Status of lipid peroxidation, glutathione, ascorbic acid, vitamin E and antioxidant enzymes in patients with pregnancy-induced hypertension. Indian J. Physiol. Pharmacol., 51: 284-288.
    PubMed    Direct Link    


  • Ludwig, M., M. Morris and C.D. Sladek, 1997. Effects of antisense oligodeoxynucleotides on peptide release from hypothalamoneurohypophysial explants. Am. J. Physiol. Regulat. Integrat. Comparat. Physiol., 41: R1441-R1446.
    Direct Link    


  • Madazli, R., A. Benian, K. Gumustas, H. Uzun, V. Ocak and F. Aksu, 1999. Lipid peroxidation and antioxidants in preeclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol., 85: 205-208.
    PubMed    


  • Meyer, N.L., B.M. Mercer, S.A. Friedman and B.M. Sibai, 1994. Urinary dipstick protein: A poor predictor of absent or severe proteinuria. Am. J. Obstet. Gynecol., 170: 137-141.
    CrossRef    Direct Link    


  • Mikhail, M.S., J. Basu, P.R. Palan, J. Furgiuele, S.L. Romney and A. Anyaegbunam, 1995. Lipid profile in women with preeclampsia: Relationship between plasma triglyceride levels and severity of preeclampsia. J. Assoc. Acad. Minor. Phys., 6: 43-45.
    Direct Link    


  • Mutlu-Turkoglu, U., E. Ademoglu, L. Ibrahimoglu, G. Aykac-Toker and M. Uysal, 1998. Imbalance between lipid peroxidation and antioxidant status in preeclampsia. Gynecol. Obstet. Invest., 46: 37-40.
    PubMed    Direct Link    


  • Narin, F., N. Narin, H. Pasaoglu, K. Uzum and R. Erdogan, 2000. Nitric oxide level in children with pulmonary hypertension. Indian J. Physiol. Pharmacol., 44: 335-339.
    PubMed    Direct Link    


  • O'Donnell, V.B., P.H. Chumley, N. Hogg, A. Bloodsworth, V.M. Darley-Usmar and B.A. Freeman, 1997. Nitric oxide inhibition of lipid peroxidation: Kinetics of reaction with lipid peroxyl radicals and comparison with alpha-tocopherol. Biochemistry, 36: 15216-15223.
    CrossRef    PubMed    Direct Link    


  • Osei-Nketiah, S., 2001. Maternal mortality at Effia nkwanta Regional Hospital, Ghana-A one year review (January-December, 1998). Ghana Med. J., 35: 124-129.


  • Ozan, H., Y. Ilcol, Y. Kimya, C. Cengiz and B. Ediz, 2002. Plasma anti-oxidant status and lipid profile in non-gravida women with a history of pre-eclampsia. J. Obstet. Gynaecol. Res., 28: 274-279.
    PubMed    Direct Link    


  • Paternoster, D.M., A. Stella, M. Mussap, M. Plebani, G. Gambaro and P.V. Grella, 1999. Predictive markers of pre-eclampsia in hypertensive disorders of pregnancy. Int. J. Gynaecol. Obstet., 66: 237-243.
    PubMed    


  • Plaa, G.L. and H. Witschi, 1976. Chemicals, drugs and lipid peroxidation. Annu. Rev. Pharmacol. Toxicol., 16: 125-142.
    CrossRef    PubMed    Direct Link    


  • Roberts, J.M., 1998. Endothelial dysfunction in preeclampsia. Semin Reprod. Endocrinol., 16: 5-15.
    PubMed    Direct Link    


  • Roberts, J.M., R.N. Taylor, T.J. Musci G.M. Rodgers, C.A. Hubel and M.K. McLaughlin, 1989. Preeclampsia: An endothelial cell disorder. Am. J. Obstet. Gynecol., 161: 1200-1204.
    CrossRef    Direct Link    


  • Sato, M., T. Miyazaki, T. Nagaya, Y. Murata, N. Ida, K. Maeda and H. Seo, 1996. Antioxidants inhibit tumor necrosis factor-alpha mediated stimulation of interleukin-8, monocyte chemoattractant protein-1 and collagenase expression in cultured human synovial cells. J. Rheumatol., 23: 432-438.
    PubMed    


  • Sattar, N., A. Bendomir, C. Berry, J. Shepherd, I.A. Greer and C.J. Packard, 1997. Lipoprotein subfraction concentrations in preeclampsia: Pathogenic parallels to atherosclerosis. Obstet. Gynecol., 89: 403-408.
    CrossRef    PubMed    Direct Link    


  • Sattar, N., I.A. Greer, J. Louden, G. Lindsay, M. McConnell, J. Shepherd and C.J. Packard, 1997. Lipoprotein subfraction changes in normal pregnancy: Threshold effect of plasma triglyceride on appearance of small, dense low density lipoprotein. J. Clin. Endocrinol. Metab., 82: 2483-2491.
    CrossRef    Direct Link    


  • Seely, E.W. and C.G. Solomon, 2003. Insulin resistance and its potential role in pregnancy-induced hypertension. J. Clin. Endocrinol. Metab., 88: 2393-2398.
    PubMed    Direct Link    


  • Shlafer, M. and B.M. Shepard, 1984. A method to reduce interference by sucrose in the detection of thiobarbituric acid-reactive substances. Anal. Biochem., 137: 269-276.
    Direct Link    


  • Sies, H., 1991. Oxidative stress: From basic research to clinical application. Am. J. Med., 91: S31-S38.
    CrossRef    PubMed    Direct Link    


  • Solomon, C.G. and E.W. Seely, 2001. Brief review: Hypertension in pregnancy: A manifestation of the insulin resistance syndrome? Hypertension, 37: 232-239.
    CrossRef    PubMed    Direct Link    


  • Vane, J.R. and R.M. Botting, 1992. The role of chemical mediators released by the endothelium in the control of the cardiovascular system. Int. J. Tissue React., 14: 55-64.
    Direct Link    


  • Williams, D.J. and M. de Swiet, 1997. The pathophysiology of pre-eclampsia. Intensive Care Med., 23: 620-629.
    PubMed    Direct Link    


  • Barham, D. and P. Trinder, 1972. An improved colour reagent for the determination of blood glucose by the oxidase system. Analyst, 97: 142-145.
    CrossRef    PubMed    Direct Link    


  • Schonfeld, G., 1979. Lipoproteins in atherogenesis. Artery, 5: 305-329.


  • Trinder, P., 1969. Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J. Clin. Pathol., 22: 158-161.
    CrossRef    PubMed    Direct Link    


  • Turpin, C.A., L. Ahenkorah, W.K.B.A. Owiredu, E.F. Laing and N. Amidu, 2008. The prevalence of the metabolic syndrome among Ghanaian Pregnancy-Induced Hypertensive patients using the World Health Organisation and the National Cholesterol Education program III criteria. J. Med. Sci., 8: 443-451.
    CrossRef    Direct Link    

  • © Science Alert. All Rights Reserved